Syngene International Ltd update on USFDA Inspection of Biologics facility

The US Food and Drug Administration (FDA) has conducted its pre-approval inspection of the Biologics facility at Bangalore from November 07, 2022 till November 15, 2022. The inspection was completed successfully without 483 observations.

Shares of Syngene International Limited was last trading in BSE at Rs. 607.45 as compared to the previous close of Rs. 628.40. The total number of shares traded during the day was 33104 in over 2461 trades.

The stock hit an intraday high of Rs. 634.85 and intraday low of 604.85. The net turnover during the day was Rs. 20372833.00.

Source : Equity Bulls

Keywords

SyngeneInternational INE398R01022 PreApprovalInspection USFDA BiologicsFacility